BioSpace News Archive

Perimeter Medical Imaging AI, Inc. (TSXV:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need, announced today that Jeremy Sobotta, Perimeter’s Chief Executive Officer, will participate in the following virtual investor conferences

Medolife Rx, Inc., a majority owned subsidiary of Quanta, Inc., announced that Medolife and CURE Pharmaceutical Holding Corp. signed a Collaboration and Joint Development Agreement on February 7, 2021.

Additional study sites will accelerate patient enrollment. Preliminary data shows Ampion improves all-cause mortality.

Akers Biosciences, Inc. (Nasdaq: AKER), with its proposed merger partner MyMD Pharmaceuticals, Inc. (“MyMD”), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, today announced new data from a study conducted by Eurofins Discovery Phenotypic Center of Excellence.

Phase Genomics, Inc., the biotech leader providing proximity-ligation solutions for the genomics community, announced today the receipt of a $1.7MM grant from the National Institute of Allergy and Infectious Diseases (NIAID).

Florica Therapeutics, Inc. has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $255,678 to work on the Hypothalamus Stem Cell Exosomes for Treatment of COVID-19 project.

AbFero Pharmaceuticals, Inc., a privately-held clinical stage pharmaceutical company dedicated to treating diseases of iron overload, today announced the initiation of a Phase 1 study of its lead iron chelator, SP-420, in myelodysplastic (MDS) and myelofibrosis patients (MF) with transfusional iron overload (TIO).

Picwell, Inc. has today announced that Jon Kaplan has been appointed to the company’s Board of Directors.

Pyrus announces a strategic partnership with RP Canon Medical Systems for the digital transformation and streamlining of processes in the distribution of diagnostic imaging equipment.

The escalating prevalence of skin diseases such as psoriasis, scars, eczema, acne, and others, will generate extensive demand for the dermatology devices market.